Phase II trial of topotecan as a 21-day continuous infusion in patients with advanced or metastatic adenocarcinoma of the pancreas
Autor: | Stevenson, J. P., Scher, R. M., Kosierowski, R., Fox, S. C., Simmonds, M., Yao, K.-S., Green, F., Broom, C., Fields, S. Z., Krebs, J. B. |
---|---|
Zdroj: | European Journal of Cancer; 1998, Vol. 34 Issue: 9 p1358-1362, 5p |
Databáze: | Supplemental Index |
Externí odkaz: |